Novel therapies in myeloma: selinexor, venetoclax, among others
Heinz Ludwig et al.
Venetoclax for multiple myeloma - mechanism of action and next steps
COMy 2016: Highlights from Day 2
Arnon Nagler et al.
bb2121 anti-BCMA CAR T-cell therapy in relapsed/refractory MM
Immunotherapy highlights in multiple myeloma at ASH 2016
Niels van de Donk